Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine

Eur J Dermatol. 2013 Sep-Oct;23(5):710-1. doi: 10.1684/ejd.2013.2132.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Azacitidine / therapeutic use
  • Bone Marrow / pathology*
  • Cell Transformation, Neoplastic
  • Humans
  • Langerhans Cells / pathology
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / etiology
  • Leukemia, Myeloid, Acute / pathology*
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / pathology*
  • Skin Diseases / etiology
  • Skin Diseases / pathology*

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine